Flexibility of Markov modeling for clinical pharmacoeconomics: illustration for cost-effectiveness in early Parkinson's disease

Postma, M. J. & Boersma, C., Jan-2012, In : Expert Review of Clinical Pharmacology. 5, 1, p. 1-4 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalExpert Review of Clinical Pharmacology
Issue number1
Publication statusPublished - Jan-2012


  • Antiparkinson Agents, Cost-Benefit Analysis, Economics, Pharmaceutical, Humans, Markov Chains, Parkinson Disease, Time Factors

ID: 13841195